Company intelligence / Profile preview

illumiSonics

Waterloo, Ontario, Canada

Ownership: Private
Employees: ~20
Development stage: Other

Overview

illumiSonics has developed and is commercializing proprietary, advanced optical imaging systems for pre-clinical and clinical applications. Their MLI and PARS technologies enable high-resolution, label-free tissue imaging, supporting novel cancer diagnostics and other pathology applications. No clinical trial results are cited, as the company is at/near commercial launch of its imaging platforms, not therapeutics.[1][2][3]

Therapeutic areas: OncologyOtherOphthalmology
Modalities: Device
Industry: Pathology

Partnerships

PhotoMedicine Labs (University of Waterloo)

Beyond the preview

Go deeper on illumiSonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on illumiSonics.

Explore the full profile